Lahoy, Jm L.

HRN: 24-69-01  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2024
CEFTAZIDIME 1GM (VIAL)
03/13/2024
03/20/2024
IV
150 Mg
Q8
PCAP D
Waiting Final Action 
03/13/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/13/2024
03/20/2024
IV
70 Mg
Q24
PCAP D
Waiting Final Action 
03/16/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/16/2024
03/22/2024
IVT
300mg
Q6hrs
Pcap C; Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: